Influenza Vaccination

OSIVAX Belgique’s clinical research activity is centered on influenza prevention, with interest in vaccine-based protection for healthy adults. The sponsor’s work focuses on immune response and protection following administration of an influenza vaccine candidate.

• Influenza immunisation
• Vaccine-induced immunity
• Seasonal respiratory infection prevention

Its research landscape reflects a targeted focus on adult vaccination and the evaluation of protective immune responses in the context of influenza control.